C E Clarke. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsHumansIncidenceJapan/epidemiologyMethylprednisolone/administration & dosageMethylprednisolone/pharmacologyMethylprednisolone/therapeutic useNeuroleptic Malignant Syndrome/epidemiologyNeuroleptic Malignant Syndrome/etiologyNeuroprotective Agents/administration & dosageNeuroprotective Agents/pharmacologyNeuroprotective Agents/therapeutic useParkinson Disease/drug therapy
Substances: See more » Antiparkinson AgentsNeuroprotective AgentsMethylprednisolone
Year: 2004 PMID: 14966183 PMCID: PMC1738992
Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN: 0022-3050 Impact factor: 10.154